Mirion Technologies, Inc. Class A (MIR)

Over the past six months, Mirion Technologies (MIR) stock has experienced notable movements, with an all-time high closing price of $29.75 on October 29, 2025. The 52-week high stock price reached $30.28, while the 52-week low was $12.00. As of February 6, 2026, the closing stock price was $24.07. A significant event was the company's Q3 2025 earnings report on October 29, 2025, where Mirion Technologies posted an earnings per share (EPS) of $0.12, exceeding analysts' expectations of $0.10 by 20.00%. The company also announced record fourth quarter and full year 2024 financial results on February 11, 2025, with revenues increasing 10.4% to $254.3 million compared to the same period in 2023, and a GAAP net income of $15.9 million, a 210% improvement from a net loss in the prior year. Insider selling activity has also been observed during this period.

Mirion Technologies' business exhibits some seasonality, particularly concerning cash flow, with the second quarter typically being the lightest cash flow quarter of the year. This is primarily driven by the timing of cash tax payments and working capital being a seasonal use of cash. Despite this, the company's business model is considered resilient, with over 70% of its revenue being recurring or repeat in nature. Additionally, approximately 80% of its nuclear power-based revenue is tied to the installed base, indicating a stable and predictable revenue stream from existing infrastructure.

Mirion Technologies, Inc. (MIR) is a global leader in radiation detection, measurement, analysis, and monitoring products and services, operating within the Industrial Goods sector, specifically in the Electronic Equipment industry. The company operates through two primary segments: Medical, and Nuclear & Safety. The Medical Segment focuses on enhancing healthcare delivery and safety through radiation oncology quality assurance, dosimetry solutions, and radionuclide therapy products. The Nuclear & Safety Segment addresses critical radiation safety, measurement, and analysis applications, providing personal radiation detection equipment, analysis tools, and monitoring solutions. Mirion serves a diverse customer base including hospitals, laboratories, government agencies, and power companies.

Mirion Technologies, Inc. has a significant global presence, providing its products and services across North America, Europe, and the Asia Pacific regions. The company operates in 13 countries.

Mirion Technologies has maintained a positive brand reputation over the past year, marked by strategic partnerships, product innovations, and industry recognition. Mirion Technology strengthened the IAEA's New Environmental Radiochemistry Laboratory in January 2026. The Vital® Platform from Mirion Technologies was recognized in the 2025 Power Technology Excellence Awards in December 2025, and Mirion completed the acquisition of Paragon Energy Solutions. Other events contributing to its reputation include the introduction of a new hub for Radiopharma Solutions in October 2025, and partnerships with the IAEA in September 2025 to enhance radiation safety globally.

Mirion Technologies, Inc. has substantial institutional ownership, with 612 institutional owners and shareholders holding a total of 294,558,792 shares. Major institutional shareholders include BlackRock, Inc. and Vanguard Group Inc. Institutional ownership accounts for approximately 84.3% of the company's shares. Individual ownership accounts for about 4.9% of the shares, with notable individual owners including Thomas Logan, Brian Schopfer, and Emmanuelle Lee.